A detailed history of Utah Retirement Systems transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Utah Retirement Systems holds 18,800 shares of ROIV stock, worth $215,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,800
Previous 20,100 6.47%
Holding current value
$215,824
Previous $211,000 6.16%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.36 - $11.74 $13,468 - $15,262
-1,300 Reduced 6.47%
18,800 $198,000
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $3,947 - $4,720
400 Added 2.03%
20,100 $211,000
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $6,704 - $9,264
800 Added 4.23%
19,700 $221,000
Q3 2023

Nov 14, 2023

BUY
$9.76 - $13.19 $55,632 - $75,183
5,700 Added 43.18%
18,900 $220,000
Q2 2023

Aug 14, 2023

BUY
$7.09 - $10.08 $93,588 - $133,056
13,200 New
13,200 $133,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.09B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.